
Andrew Eisenstein
Get their honest, personalized take on your startup.
Sign in to pitch Andrew →At a glance
- Full Name
- Andrew V. Eisenstein
- Title
- Founding Partner
- Firm
- Iron Stone Real Estate Partners (also operates Iron Stone Strategic Capital Partners)
- Firm Type
- Private real estate investment, private equity and development company
- Investment Stage
- Opportunistic / value-add real estate; special-situations investing and distressed/mortgage-debt acquisition (note: not a venture "seed" investor — the firm invests in real estate assets and operating companies, not early-stage startups)
- Check Size
- Project-level; the firm has completed roughly $1 billion in real estate projects since 1995, with Eisenstein personally credited with $400M+ in private equity and real estate transactions
- Target Company Profile
- Value-add real estate assets, real estate-related operating companies, and the assumption/acquisition of mortgage notes — often complex or distressed institutional properties (e.g., former hospital and university campuses)
- Sector Focus
- Life sciences, healthcare/medical, educational/institutional, specialty commercial, and multifamily/mixed-use real estate
- Geographic Focus
- Philadelphia metropolitan area, Pennsylvania
- Location
- FMC Tower, 2929 Walnut Street, Suite 1540, Philadelphia, PA 19104
Background
Andrew V. Eisenstein is a Founding Partner of Iron Stone Real Estate Partners, a Philadelphia-based real estate private equity and development firm he helped establish in the mid-1990s. He holds a B.S. from the University of Pennsylvania. Since the mid-1990s he has completed over $400 million in private equity and real estate transactions personally, and the firm as a whole has completed approximately $1 billion in real estate-related projects since 1995.
Eisenstein came up through the operational side of real estate, with a hands-on background in general contracting, historic property restoration, and high-rise construction. He has translated that operating expertise into an investment model focused on opportunistic real estate development, special-situations investing, and mortgage-debt (note) acquisition — often taking on large, complex institutional assets that other buyers avoid. Iron Stone today develops, owns and manages in excess of three million square feet of medical, life-science and mixed-use property across the Philadelphia region, working closely with the city's leading universities, hospitals and institutions.
Beyond Iron Stone, Eisenstein is active in Philadelphia civic and nonprofit life. He has served as a trustee of the Settlement Music School and previously served on the board of Legacy Youth Tennis (formerly the Legacy Youth Tennis and Education organization). He leads Iron Stone alongside partners Jason Friedland, Matthew Canno, Michael Pearson and Sam Patterson.
Investment Thesis & Focus
- Value-add and opportunistic real estate: The firm targets undervalued, complex or distressed assets it can reposition — its self-described niche is "value-added real estate assets, the acquisition of real estate related operating companies, and the assumption of mortgage notes."
- Institutional adaptive reuse: A signature play is buying large legacy institutional campuses (hospitals, universities) and converting them to modern life-science, lab, medical, educational and mixed-use space.
- Sector concentration: Life sciences, healthcare, education/institutional, specialty commercial, and multifamily/mixed-use.
- Local, relationship-driven: Focus is concentrated in the Philadelphia metro, and deals are typically done in partnership with the city's "top companies, universities, and institutions."
- Special situations / debt: Willingness to acquire mortgage notes and assets out of bankruptcy or distress, using construction and restoration expertise to unlock value.
Notable Investments
- Race Street Labs (former Hahnemann University Hospital complex) — Acquired the Hahnemann portfolio out of bankruptcy for ~$36 million in 2021; redeveloped ~180,000 sq ft into life-science/lab space. First tenant Zahav Biosciences (8,200 sq ft, 2024); other tenants include Drexel University College of Medicine and the Sbarro Health Research Organization.
- The Provident Campus — ~325,000 sq ft public-health and educational space development.
- 4601 Market Street — Major mixed-use/commercial redevelopment in West Philadelphia.
- MCP Hospital, Girard Medical Center, and St. Christopher's Hospital for Children — Campus transformations/redevelopments of former medical facilities.
Unlock the full research
Get how to approach them, recent activity, sources, contact links — plus pitch their AI twin for a candid read on your raise.
One-time. Stays unlocked for you.